OPTIMER PHARMACEUTICALS INC Proceeds from Common Stock Issued
OPTIMER PHARMACEUTICALS INC reported Proceeds from Common Stock Issued of $9.39 million for the 6-month period ending 2013-06-30, per its 10-Q filed 2013-08-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2013-08-07
- OPTIMER PHARMACEUTICALS INC proceeds from issuance of common stock for the quarter ending 2013-06-30 was $8.05M, a 102.90% increase year-over-year.
- OPTIMER PHARMACEUTICALS INC proceeds from issuance of common stock for the quarter ending 2013-03-31 was $1.34M, a 362.96% increase year-over-year.
- OPTIMER PHARMACEUTICALS INC proceeds from issuance of common stock for the quarter ending 2012-12-31 was $749.00K.
- OPTIMER PHARMACEUTICALS INC proceeds from issuance of common stock for the quarter ending 2012-09-30 was $1.88M, a 1173.23% increase year-over-year.
- OPTIMER PHARMACEUTICALS INC proceeds from issuance of common stock for fiscal 2012 was $6.88M, a 91.02% decline from fiscal 2011.
- OPTIMER PHARMACEUTICALS INC proceeds from issuance of common stock for fiscal 2011 was $76.66M, a 45.17% increase from fiscal 2010.
- OPTIMER PHARMACEUTICALS INC proceeds from issuance of common stock for fiscal 2010 was $52.80M, a 58.11% increase from fiscal 2009.
- OPTIMER PHARMACEUTICALS INC proceeds from issuance of common stock for fiscal 2009 was $33.40M.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|
| 2013-06-30 | $8.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $9.39M 10-Q · filed 2013-08-07 | $10.13M derived: sum of 3 quarters · filed 2013-08-07 | $12.01M derived: sum of 4 quarters · filed 2013-08-07 |
| 2013-03-31 | $1.34M 10-Q · filed 2013-05-10 | $2.09M derived: sum of 2 quarters · filed 2013-05-10 | $3.96M derived: sum of 3 quarters · filed 2013-05-10 | $7.93M derived: sum of 4 quarters · filed 2013-08-07 |
| 2012-12-31 | $749.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $2.63M derived: sum of 2 quarters · filed 2013-03-18 | $6.59M derived: sum of 3 quarters · filed 2013-08-07 | $6.88M 10-K · filed 2013-03-18 |
| 2012-09-30 | $1.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $5.84M derived: sum of 2 quarters · filed 2013-08-07 | $6.13M 10-Q · filed 2012-11-02 | $372.60K derived: sum of 4 quarters · filed 2013-08-07 |
| 2012-06-30 | $3.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $4.26M 10-Q · filed 2013-08-07 | -$1.50M derived: sum of 3 quarters · filed 2013-08-07 | -$1.36M derived: sum of 4 quarters · filed 2013-08-07 |
| 2012-03-31 | $289.03K 10-Q · filed 2013-05-10 | -$5.47M derived: sum of 2 quarters · filed 2013-05-10 | -$5.32M derived: sum of 3 quarters · filed 2013-05-10 | -$3.06M derived: sum of 4 quarters · filed 2013-05-10 |
| 2011-12-31 | -$5.76M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$5.61M derived: sum of 2 quarters · filed 2013-03-18 | -$3.35M derived: sum of 3 quarters · filed 2013-03-18 | $76.66M 10-K · filed 2013-03-18 |
| 2011-09-30 | $147.46K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $2.41M derived: sum of 2 quarters · filed 2012-11-02 | $82.42M 10-Q · filed 2012-11-02 | $83.41M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | $2.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $82.27M 10-Q · filed 2012-08-03 | $83.26M derived: sum of 3 quarters · filed 2013-03-18 | $83.30M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | $80.01M 10-Q · filed 2012-05-10 | $81.00M derived: sum of 2 quarters · filed 2013-03-18 | $81.04M derived: sum of 3 quarters · filed 2013-03-18 | |
| 2010-12-31 | $987.68K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $1.03M derived: sum of 2 quarters · filed 2013-03-18 | $52.80M 10-K · filed 2013-03-18 | |
| 2010-09-30 | $41.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $51.82M 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | $51.77M 10-Q · filed 2011-08-04 | |||
| 2009-12-31 | $33.40M 10-K · filed 2012-03-08 |